Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 41 (EEF1A1P41) is a processed pseudogene originating from the *EEF1A1* gene, which ordinarily encodes a highly conserved GTPase involved in aminoacyl-tRNA delivery to the ribosome during protein synthesis. The *EEF1A1* gene has a large number of dispersed pseudogenes throughout the human genome—over 40 have been described. These pseudogenes, including EEF1A1P41, rarely have described biological functions and are not known to produce functional proteins. Although some *EEF1A1* pseudogenes have been correlated with various diseases (primarily cancers), there is no specific evidence linking EEF1A1P41 to disease or therapeutic applications.
None established, as no drugs are known to act via this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 41 (EEF1A1P41).